FDA works to re­duce dog test­ing in drug de­vel­op­ment

FDA re­searchers are work­ing to de­vel­op a new in­for­mat­ics mod­el to re­duce the re­liance on dogs to con­duct stud­ies in an­i­mal drug de­vel­op­ment.

The agency’s new study, which was pro­posed on Fri­day, is in­tend­ed to aid an­i­mal drug de­vel­op­ers in con­duct­ing cer­tain re­search with­out the need for prod­uct test­ing on dogs.

An­i­mal drug de­vel­op­ers would be able to use the new mod­el as a mech­a­nism for com­par­ing blood lev­els of cer­tain oral­ly-ad­min­is­tered ca­nine drugs to sup­port FDA ap­proval based on their ex­ist­ing re­search.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.